doi:10.1007/s10067-016-3168-2
Andreeff M , Tafuri A, Bettelheim P, Valent P, Estey E, Lemoli R, Homge M, Collins D, Goodacre A, Clarkson B, Mandelli F, Deisseroth A
We assume that the bioavailability of a dose is 75%
Physician-supervised Pharmaceutical-grade peptides from licensed compounding pharmacies TL;DR The best way to take BPC-157 for most people is a daily subcutaneous injection of 250500 mcg , delivered into the subcutaneous fat near the injury site, for a 48 week cycle for acute injuries or 812 weeks for chronic conditions
[3] An editorial in Thyroid , written by Peter Andreas Kopp in 2014, found that patients remain symptomatic (that is, they may experience symptoms like fatigue) despite having normal thyroid hormone levels
All the subjects had a positive GH secretory response to the combined administration with no differences observed between men and women